Vault-13

Sands Capital Alternatives, LLC

ARLINGTON, VA · CIK 1846444 · 13F filing filed 2024-08-13

SEC-registered investment adviser since 2011 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Arlington, VA (main office)United States United Statesabout 60
Fitzrovia LondonUnited Kingdom United Kingdom2
San Francisco, CAUnited States United States2
New York City, NYUnited States United States1
San Juan, PRUnited States United States1
SingaporeSingapore Singapore

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$298.6m reported value -28.0% vs Q1 2024
20positions
98.6%in top 10
0 new 3 added 7 reduced 0 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NU HLDGS LTD ORD SHS CL A NU NU 7,328,294 $94.5m31.64% 31.64% ReducedShares held: Q3 2023 9.2m, Q4 2023 9.2m, Q1 2024 9.2m, Q2 2024 7.3m -1.8m -1,827,367 -20.0%
2 KLAVIYO INC COM SER A KVYO KVYO 3,516,221 $87.5m29.31% 29.31% AddedShares held: Q3 2023 469.4k, Q4 2023 471.3k, Q1 2024 3.5m, Q2 2024 3.5m +1.3k +1,324 0.0%
3 DOORDASH INC CL A DASH DASH 423,091 $46.0m15.41% 15.41% ReducedShares held: Q3 2023 603.5k, Q4 2023 603.3k, Q1 2024 523.1k, Q2 2024 423.1k -100.0k -100,000 -19.1%
4 UIPATH INC CL A PATH PATH 1,155,246 $14.6m4.91% 4.91% ReducedShares held: Q3 2023 3.1m, Q4 2023 2.3m, Q1 2024 2.3m, Q2 2024 1.2m -1.1m -1,148,206 -49.9%
5 SNOWFLAKE INC CL A SNOW SNOW 108,304 $14.6m4.90% 4.90% ReducedShares held: Q3 2023 215.8k, Q4 2023 215.8k, Q1 2024 215.6k, Q2 2024 108.3k -107.3k -107,311 -49.8%
6 ACRIVON THERAPEUTICS INC COMMON STOCK ACRV ACRV 2,122,605 $12.3m4.12% 4.12% AddedShares held: Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 1.7m, Q2 2024 2.1m +470.0k +470,000 28.4%
7 10X GENOMICS INC CL A COM TXG TXG 481,770 $9.4m3.14% 3.14% UnchangedShares held: Q3 2023 481.8k, Q4 2023 481.8k, Q1 2024 481.8k, Q2 2024 481.8k
8 ACUMEN PHARMACEUTICALS INC COM ABOS ABOS 3,417,075 $8.3m2.77% 2.77% UnchangedShares held: Q3 2023 3.4m, Q4 2023 3.4m, Q1 2024 3.4m, Q2 2024 3.4m
9 TARSUS PHARMACEUTICALS INC COM TARS TARS 170,000 $4.6m1.55% 1.55% UnchangedShares held: Q3 2023 260.0k, Q4 2023 260.0k, Q1 2024 170.0k, Q2 2024 170.0k
10 CANDEL THERAPEUTICS INC COM CADL CADL 405,837 $2.5m0.84% 0.84% ReducedShares held: Q3 2023 811.7k, Q4 2023 811.7k, Q1 2024 811.7k, Q2 2024 405.8k -405.9k -405,900 -50.0%
11 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 724,873 $1.6m0.54% 0.54% UnchangedShares held: Q3 2023 724.9k, Q4 2023 724.9k, Q1 2024 724.9k, Q2 2024 724.9k
12 908 DEVICES INC COM MASS MASS 237,258 $1.2m0.41% 0.41% UnchangedShares held: Q3 2023 237.3k, Q4 2023 237.3k, Q1 2024 237.3k, Q2 2024 237.3k
13 SPRUCE BIOSCIENCES INC COM COM 787,007 $409.2k0.14% 0.14% UnchangedShares held: Q3 2023 787.0k, Q4 2023 787.0k, Q1 2024 787.0k, Q2 2024 787.0k
14 COUPANG INC CL A CPNG CPNG 11,931 $250.0k0.08% 0.08% UnchangedShares held: Q3 2023 8.4k, Q4 2023 10.5k, Q1 2024 11.9k, Q2 2024 11.9k
15 ABSCI CORPORATION COM ABSI ABSI 57,804 $178.0k0.06% 0.06% UnchangedShares held: Q3 2023 57.8k, Q4 2023 57.8k, Q1 2024 57.8k, Q2 2024 57.8k
16 SAMSARA INC COM CL A IOT IOT 4,239 $142.9k0.05% 0.05% AddedShares held: Q3 2023 934.7k, Q4 2023 3.6k, Q1 2024 3.6k, Q2 2024 4.2k +669 +669 18.7%
17 DATADOG INC CL A COM DDOG DDOG 1,015 $131.6k0.04% 0.04% UnchangedShares held: Q3 2023 1.4k, Q4 2023 1.0k, Q1 2024 1.0k, Q2 2024 1.0k
18 TOAST INC CL A TOST TOST 4,945 $127.4k0.04% 0.04% ReducedShares held: Q3 2023 7.1k, Q4 2023 7.9k, Q1 2024 5.9k, Q2 2024 4.9k -1.0k -1,002 -16.9%
19 CROWDSTRIKE HLDGS INC CL A CRWD CRWD 221 $84.7k0.03% 0.03% ReducedShares held: Q3 2023 865, Q4 2023 344, Q1 2024 279, Q2 2024 221 -58 -58 -20.8%
20 GITLAB INC CLASS A COM GTLB GTLB 658 $32.7k0.01% 0.01% UnchangedShares held: Q3 2023 658, Q4 2023 658, Q1 2024 658, Q2 2024 658

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ACUMEN PHARMACEUTICALS INC ABOS · 13G · filed 2025-08-13 ABOS 5.6%≈ $9.1m 13G 2025-08-13